期刊文献+

二次等离子电切术在非肌层浸润性膀胱肿瘤中的应用 被引量:10

Application of the repeat plasmakinetic resection in non-muscular invasive bladder tumor
原文传递
导出
摘要 目的讨论二次等离子电切术在非肌层浸润性膀胱肿瘤中的应用价值。方法回顾性分析2017年7月一2019年1月于蚌埠医学院第--附属医院泌尿外科行膀胱肿瘤等席子电切术的非肌层浸润性膀胱肿瘤患者113例。其中43例于首次等离子电切术后4~6周行二次电切术的患者为观察组,其余行单次等离子电切术患者70例为对照组。记录并分析以下临床资料,包括一般资料:性别、年龄、BMI、肿瘤大小、数目、术前分期、病理分级;手术相关情况:术后留置导尿时间、术中及术后相关并发症等;术后病理及预后资料:二次等离子电切病理阳性率.2组患者术后肌层浸润率及随访12个月后局部复发率等。结果2组患者一般资料和手术相关情况差异无统计学意义(均P>0.05);观察组3例患者(6.98%)二次等离子电切术后病理可见尿路上皮肿瘤细胞;观察组一次等离子电切术后与对照组术后病理明确肌层浸润率(6.98%vs.7.14%)比较,差异无统计学意义(P>0.05);而二次等离子电切术后肌层浸润率明显高于对照组(20.93%vs.7.14%),差异有统计学意义(P<0.05);观察组复发率明显低于对照组(2.94%vs.18.46%),差异有统计学意义(P<0.05)。结论二次等离子电切术可以最大限度清除肿瘤组织,提供精准的病理分期,降低复发率,且术中及术后并发症无明显增加。非肌层浸润性膀胱肿瘤行二次等离子电切术可以使患者获益,值得临床推广。 Objective To discuss the value of the repeat plasmakinetic resection(Re-PKRBt)in non-muscular invasive bladder tumor.Methods A retrospective analysis was performed on 113 patients with non-muscular invasive bladder tumor who underwent plasmakinetic resection of bladder tumor in the Department of Urology,the First Affiliated Hospital of Bengbu Medical College from July 2017 to January 2019.Among them,43 patients who underwent Re-PKRBt 4—6 weeks after first plasmakinetic resection were in observation group,while the remaining 70 patients who underwent single plasmakinetic resection were in control group.The following clinical data were recorded and analyzed,including the general data:gender,age,BMI,tumor size,number,preoperative staging,and pathological grading;the operation related information:indwelling catheterization time,intraoperative and postoperative complications,etc.;the postoperative pathological and prognostic data:positive rate of Re-PKRBt,postoperative pathological staging of the two groups of patients and local recurrence rate after 12 months of follow-up,etc.Results There was no significant difference between the two groups in general information and operation related information(all P>0.05).In the observation group,3 patients(6.98%)showed urothelial tumor cells after Re-PKRBt.There was no significant difference concerning the invasion rate of muscle layer between first plasmakinetic resection in the observation group and the control group(6.98%vs.7.14%).The invasion rate of muscle layer after secondary plasmakinetic resection in the observation group was significantly higher than that of the control group(20.93%vs.7.14%),and the difference was statistically significant(P<0.05).The recurrence rate of the observation group was significantly lower than that of the observation group(2.94%vs.18.46%),and the difference was statistically significant(P<0.05).Conclusion Re-PKRBt can remove tumor tissues to the maximum extent,provide accurate pathological staging and reduce recurrence rate,and increase of intraoperative and postoperative complications is insignificantly.Re-PKRBt for non-muscular invasive bladder tumors can benefit the patients and is worthy of clinical promotion.
作者 李立强 郭园园 岳晓娥 王成勇 李庆文 刘建民 刘贝贝 LI Li-qiang;GUO Yuan-yuan;YUE Xiao-e;WANG Cheng-yong;LI Qing-wen;LIU Jian-min;LIU Bei-bei(Department of Urology,the First Affliated Hospital of Bengbu Medical College,Bengbu,Anhui 233004,China)
出处 《中华全科医学》 2020年第10期1629-1632,共4页 Chinese Journal of General Practice
基金 国家自然科学基金青年科学基金(81702495) 安徽省自然科学青年基金(1808085QH279) 安徽省教育厅高校自然科学基金重点项目(KJ2019A0308)。
关键词 非肌层浸润性膀胱癌 二次电切术 临床应用 Non-muscular invasive bladder cancer Repeat plasmakinetic resection Clinical application
  • 相关文献

参考文献13

二级参考文献87

  • 1陶逸然,金讯波,王慕文,赵勇,于潇.吉西他滨联合顺铂新辅助化疗治疗肌层浸润性膀胱癌的临床疗效观察[J].泌尿外科杂志(电子版),2014,6(2):23-28. 被引量:12
  • 2郝捷,陈万青.膀胱癌-2012年中国肿瘤登记年报[R].北京:军事医学科学出版社,2012:97.
  • 3van den Bosch S, Alfred Witjes J. Long term cancer spe- cific survival in patients with high risk non muscle inva- sive bladder cancer and tumor progression: a systematic review [ J ]. Eur Urol, 2011,60 ( 3 ) :493-500.
  • 4He D, Fan J, Wu K, et al. Novel green-light KTP laser en bloc enucleation for nonmuscle-invasive bladder canc- er: technique and inatial cllnical experience [ J ]. J En- dourol, 2014,28 (8) :975-979.
  • 5Pietrow P K, Smith J A Jr. Laser treatment for invasive and noninvasive carcinoma of bladder [ J ][J Endourol, 2001,15(4) :415-418.
  • 6Syed H A, Biyani C S, Bryan N, et al. Holmium: YAG laser treatment of recurrent superficial bladder carcinoma : initial clinical experience [ J]. J Endourol, 2001,15 ( 6 ) : 625 -627.
  • 7Babjuk M,Burger M,Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder : update 2013[J] . Eur Urol, 2013 , 64 ( 4 ) : 639-653. DOI: 10. 1016/j. eururo. 2013. 06. 003.
  • 8Jakse G, Algaba F, Malmstrom PU, et al. A second-look TUR inT1 transitional cell carcinoma: why? [ J ]. Eur Urol, 2004,45(5) :539-546. DOI: 10. 1016/j. eururo. 2003. 12.016.
  • 9Herr HW,Donat SM,Daibagni G. Can restaging transurethralresection of T1 bladder cancer select patients for immediatecystectomy? [J]. J Urol, 2007,177 (1 ) :75-79. DOI: 10. 1016/j. juro. 2006. 08. 070.
  • 10Divrik RT,Sahin AF, Yildirim U, et al. Impact of routine secondtransurethral resection on the long-term outcome of patients withnewly diagnosed pTl urothelial carcinoma with respect torecurrence,progression rate,and disease-specific survival : aprospective randomised clinical trial[ J]. Eur Urol, 2010,58(2):185-190. DOI: 10. 1016/j. eururo. 2010. 03. 007.

共引文献109

同被引文献63

引证文献10

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部